Rishu Takimoto
Impact in
- Hematology top 0.5%
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Hepatology top 1%
- Liver physiology and pathology
Papers in
- Oncology 38
- Cancer-related Molecular Pathways 8
- Co-authors
- Masayoshi Kobune (90 shared papers)Yoshiro Niitsu (59 shared papers)Wafik S. El‐Deiry (8 shared papers)Junji Kato (84 shared papers)Tetsuji Takayama (33 shared papers)Yasushi Sato (74 shared papers)Koji Miyanishi (68 shared papers)Yutaka Kawano (40 shared papers)
- Journals
- Blood (10 papers)Anticancer Research (9 papers)Gastrointestinal Endoscopy (7 papers)International Journal of Hematology (6 papers)Experimental Hematology (5 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Rishu Takimoto
148 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 118
- Hematology 1.1k
- Hepatology 637
- Genetics 861
- Oncology 1.4k
- Molecular Biology 2.4k
Countries citing papers authored by Rishu Takimoto
This map shows the geographic impact of Rishu Takimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishu Takimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishu Takimoto more than expected).
Fields of papers citing papers by Rishu Takimoto
This network shows the impact of papers produced by Rishu Takimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishu Takimoto. The network helps show where Rishu Takimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Rishu Takimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 499 | |
| 2 | 2005 | 488 | |
| 3 | 2003 | 447 | |
| 4 | 2000 | 286 | |
| 5 | 2001 | 187 | |
| 6 | Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. | 2001 | 181 |
| 7 | 2001 | 165 | |
| 8 | 2001 | 157 | |
| 9 | 2007 | 148 | |
| 10 | 2002 | 124 | |
| 11 | 2003 | 120 | |
| 12 | 2002 | 106 | |
| 13 | 2009 | 104 | |
| 14 | Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. | 2003 | 96 |
| 15 | 2006 | 95 | |
| 16 | 2007 | 86 | |
| 17 | 2015 | 85 | |
| 18 | 2004 | 85 | |
| 19 | 2003 | 84 | |
| 20 | 2013 | 81 |
About Rishu Takimoto
Rishu Takimoto is a scholar working on Molecular Biology, Oncology, Hematology, Surgery and Genetics, having authored 155 papers that have together received 5.8k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (9 papers), Acute Myeloid Leukemia Research (9 papers), Cancer-related Molecular Pathways (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Hemoglobinopathies and Related Disorders (7 papers), Hepatitis B Virus Studies (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Platelet Disorders and Treatments (6 papers). The work is most often cited by research in Hematology (1.1k citations), Hepatology (637 citations), Genetics (861 citations), Oncology (1.4k citations) and Molecular Biology (2.4k citations). Rishu Takimoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masayoshi Kobune, Yoshiro Niitsu, Wafik S. El‐Deiry, Junji Kato, Tetsuji Takayama, Yasushi Sato, Koji Miyanishi, Yutaka Kawano, Tsutomu Sato and Takuya Matsunaga. Their work appears in journals such as Blood, Anticancer Research, Gastrointestinal Endoscopy, International Journal of Hematology and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.